tiprankstipranks
Lakefront Biotherapeutics (LKFT)
NASDAQ:LKFT
US Market
LKFT
Lakefront Biotherapeutics
RESEARCH TOOLSreports
Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Financial Statements

549 Followers

Lakefront Biotherapeutics Financial Overview

Lakefront Biotherapeutics's market cap is currently $1.83B. The company's EPS TTM is $7.42; its P/E ratio is 28.08; Lakefront Biotherapeutics is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 1.11B€ 275.65M€ 239.72M€ 241.25M€ 484.85M
Gross Profit€ 1.08B€ 240.79M€ 239.72M€ 241.25M€ 483.22M
Operating Income€ 501.39M€ -188.34M€ -88.26M€ -131.06M€ -165.60M
EBITDA€ 358.96M€ 43.33M€ 51.04M€ 3.87M€ -100.93M
Net Income€ 320.88M€ 74.08M€ 211.70M€ -217.99M€ -125.42M
Balance Sheet
Cash & Short-Term Investments€ 3.00B€ 3.12B€ 3.68B€ 4.09B€ 4.70B
Total Assets€ 3.41B€ 4.14B€ 4.36B€ 4.73B€ 5.19B
Total Debt€ 6.92M€ 11.72M€ 9.60M€ 21.90M€ 26.86M
Net Debt€ -80.95M€ -52.52M€ -157.21M€ -486.22M€ -2.21B
Total Liabilities€ 170.65M€ 1.24B€ 1.56B€ 2.21B€ 2.55B
Stockholders' Equity€ 3.24B€ 2.90B€ 2.80B€ 2.53B€ 2.64B
Cash Flow
Free Cash Flow€ -271.31M€ -402.14M€ -425.24M€ -537.49M€ -561.71M
Operating Cash Flow€ -257.46M€ -320.03M€ -405.97M€ -500.54M€ -503.83M
Investing Cash Flow€ 288.81M€ 220.60M€ 71.19M€ -1.25B€ 541.24M
Financing Cash Flow€ -3.27M€ -4.92M€ -5.00M€ -1.49M€ -3.88M
Currency in EUR

Lakefront Biotherapeutics Earnings and Revenue History

Income Statement >

Lakefront Biotherapeutics Debt to Assets

Balance Sheet >

Lakefront Biotherapeutics Cash Flow

Cash Flow >

Lakefront Biotherapeutics Forecast EPS vs Actual EPS

Earnings >